0001104659-21-153908.txt : 20211228 0001104659-21-153908.hdr.sgml : 20211228 20211228151523 ACCESSION NUMBER: 0001104659-21-153908 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211228 DATE AS OF CHANGE: 20211228 EFFECTIVENESS DATE: 20211228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Psy Therapeutics, Inc. CENTRAL INDEX KEY: 0001788222 IRS NUMBER: 464703014 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-426963 FILM NUMBER: 211524564 BUSINESS ADDRESS: STREET 1: 28 ATLANTIC AVE, SUITE 129 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: (617) 723-5429 MAIL ADDRESS: STREET 1: 28 ATLANTIC AVE, SUITE 129 CITY: BOSTON STATE: MA ZIP: 02110 D 1 primary_doc.xml X0708 D LIVE 0001788222 Psy Therapeutics, Inc. 28 ATLANTIC AVE, SUITE 129 BOSTON MA MASSACHUSETTS 02110 (617) 723-5429 DELAWARE PsyBrain, Inc. None Corporation true David S. Barlow c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 129 Boston MA MASSACHUSETTS 02110 Executive Officer Director Jeff Troderman c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 129 Boston MA MASSACHUSETTS 02110 Executive Officer Alan Cross c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 129 Boston MA MASSACHUSETTS 02110 Director Daniel Weiss Pick c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 129 Boston MA MASSACHUSETTS 02110 Director Jerry F. Rosenbaum c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 129 Boston MA MASSACHUSETTS 02110 Director William Wagner c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 129 Boston MA MASSACHUSETTS 02110 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2021-12-23 false true true true false 0 20400000 2772615 17627385 Amount sold includes $1,772,615 of principal and accrued interest on certain prior convertible promissory notes which were converted to First Tranche Convertible Promissory Notes. false 6 0 0 0 false Psy Therapeutics, Inc. /s/ David S. Barlow David S. Barlow Chief Executive Officer 2021-12-28